Nektar Therapeutics (NKTR) Net margin 2016–2025
Nektar Therapeutics (NKTR) net profit margin by fiscal year — reported net income divided by reported revenue.
-297.1%FY2025 · since FY2016: -92.8% → -297.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -297.1% | -176.2 pp |
| FY2024 | -120.9% | +185.5 pp |
| FY2023 | -306.3% | +93.7 pp |
| FY2022 | -400.0% | +114.1 pp |
| FY2021 | -514.0% | -223.4 pp |
| FY2020 | -290.6% | +93.8 pp |
| FY2019 | -384.5% | -441.6 pp |
| FY2018 | 57.1% | +88.5 pp |
| FY2017 | -31.4% | +61.4 pp |
| FY2016 | -92.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice